Literature DB >> 20534455

Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.

Brian D Stadinski1, Li Zhang, Frances Crawford, Philippa Marrack, George S Eisenbarth, John W Kappler.   

Abstract

A peptide derived from the insulin B chain contains a major epitope for diabetogenic CD4(+) T cells in the NOD mouse model of type 1 diabetes (T1D). This peptide can fill the binding groove of the NOD MHCII molecule, IA(g7), in a number of ways or "registers." We show here that a diverse set of NOD anti-insulin T cells all recognize this peptide bound in the same register. Surprisingly, this register results in the poorest binding of peptide to IA(g7). The poor binding is due to an incompatibility between the p9 amino acid of the peptide and the unique IA(g7) p9 pocket polymorphisms that are strongly associated with susceptibility to T1D. Our findings suggest that the association of autoimmunity with particular MHCII alleles may be do to poorer, rather than more favorable, binding of the critical self-epitopes, allowing T-cell escape from thymic deletion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534455      PMCID: PMC2890771          DOI: 10.1073/pnas.1006545107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Binding interactions between peptides and proteins of the class II major histocompatibility complex.

Authors:  Benjamin J McFarland; Craig Beeson
Journal:  Med Res Rev       Date:  2002-03       Impact factor: 12.944

Review 2.  Post-translational modifications of self antigens: implications for autoimmunity.

Authors:  Stephen M Anderton
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

Review 3.  Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands.

Authors:  Frances Crawford; Kimberly R Jordan; Brian Stadinski; Yibing Wang; Eric Huseby; Philippa Marrack; Jill E Slansky; John W Kappler
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

4.  Antigen-specific. I region-restricted interactions in vitro between tumor cell lines and T cell hybridomas.

Authors:  E Walker; N L Warner; R Chesnut; J Kappler; P Marrack
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

5.  Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.

Authors:  K H Lee; K W Wucherpfennig; D C Wiley
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

6.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.

Authors:  R R Latek; A Suri; S J Petzold; C A Nelson; O Kanagawa; E R Unanue; D H Fremont
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

7.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

8.  Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.

Authors:  Yili Li; Yuping Huang; Jessica Lue; Jacqueline A Quandt; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

9.  New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Authors:  Elise Landais; Pablo A Romagnoli; Adam L Corper; John Shires; John D Altman; Ian A Wilson; K Christopher Garcia; Luc Teyton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

View more
  118 in total

Review 1.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 2.  Endocrinology research-reflecting on the past decade and looking to the next.

Authors:  Kevan C Herold; Joseph A Majzoub; Shlomo Melmed; Merri Pendergrass; Martin Schlumberger
Journal:  Nat Rev Endocrinol       Date:  2015-10-13       Impact factor: 43.330

3.  Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Authors:  Zemin Zhou; Eduardo Reyes-Vargas; Hernando Escobar; Brant Rudd; Alan L Rockwood; Julio C Delgado; Xiao He; Peter E Jensen
Journal:  Eur J Immunol       Date:  2016-01-22       Impact factor: 5.532

Review 4.  Insulin as a key autoantigen in the development of type 1 diabetes.

Authors:  Maki Nakayama
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

5.  γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.

Authors:  M Kemal Aydintug; Li Zhang; Chao Wang; Dongchun Liang; J M Wands; Aaron W Michels; Brooke Hirsch; Brian J Day; Gongyi Zhang; Deming Sun; George S Eisenbarth; Rebecca L O'Brien; Willi K Born
Journal:  Mol Immunol       Date:  2014-05-20       Impact factor: 4.407

6.  Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells.

Authors:  Marion Pepper; Antonio J Pagán; Botond Z Igyártó; Justin J Taylor; Marc K Jenkins
Journal:  Immunity       Date:  2011-10-20       Impact factor: 31.745

7.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 8.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 9.  Targeting the trimolecular complex.

Authors:  Aaron W Michels
Journal:  Clin Immunol       Date:  2013-03-05       Impact factor: 3.969

Review 10.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.